Study reveals a new therapeutic target for aggressive type of rhabdomyosarcoma

Scientists at St. Jude Children’s Research Hospital have identified an Achilles’ heel in rhabdomyosarcoma driven by a gene fusion which revealed a promising treatment approach in the lab.

Read more: https://www.stjude.org/media-resources/news-releases/2022-medicine-science-news/new-therapeutic-target-for-aggressive-type-of-rhabdomyosarcoma.html